University of California San Francisco
Give to UCSF<p>A new study that represents a significant first step in exploring the potential of stem cells to treat neurological disease is a “natural outgrowth” of a longstanding culture of interdisciplinary collaboration in UCSF neonatology — a culture that UCSF Benioff Children's Hospital physicians David Rowitch and Donna Ferriero work hard to sustain.</p>
<p>For the first time since 1997, UCSF is embarking on a new long-range development plan to guide the University through the year 2035 and is seeking input from members of the community in the planning process.</p>
<p>Top students from UCSF's four professional schools and the Graduate Division tell why they chose to study at UCSF, one of the nation's premier health sciences universities, in a new video captured during new student orientation day.</p>
For the first time, a clinical trial led by UCSF investigators and sponsored by Stem Cells Inc., has shown that transplanted neural stem cells appear to produce myelin in the brains of four young children with an early-onset, fatal disease.
Armed with a new $10 million grant, a multi-center “dream team’’ of scientists, led by UCSF, is embarking on a groundbreaking undertaking to overcome therapeutic resistance and revolutionize treatment for patients with advanced prostate cancer.
Scientists at the UCSF-affiliated Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD) — a form of early-onset dementia similar to Alzheimer’s disease. These results lay the foundation for therapies that one day may benefit those who suffer from this and related brain diseases.
Scientists at the UCSF-affiliated Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes — and revealing new clues as to what happens when this process goes awry.
<p>Colleagues at the Gladstone and UCSF celebrated the news on Monday that Shinya Yamanaka won the Nobel Prize in Medicine for his discovery that has transformed the field of stem cell research.</p>
<p>Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes and a professor of anatomy at UCSF, has won the 2012 Nobel Prize in Physiology or Medicine for his discovery of how to transform ordinary adult skin cells into cells that are capable of developing into any cell in the human body.</p>
<p>Since 1981, when UCSF’s Gail Martin, PhD, co-discovered embryonic stem cells in mice and coined the term embryonic stem cell, UCSF has been a key player in the stem cell field. Today, Shinya Yamanaka became the fifth UCSF scientist to win the Nobel Prize.</p>
<p>Gladstone and UCSF leaders will participate in a Nobel Prize press conference at the Gladstone Institute at 8:30 a.m. Pacific Time (PT). Shinya Yamanaka will join via videoconference from Japan.</p>
<p>Here are answers to frequently asked questions about induced pluripotent stem cells, or iPS cells, the type of cell that has been reprogrammed from an adult cell, such as a skin or blood cell.</p>